−83.5
Prelude Therapeutics Inc
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−83.7
FY23:
−107
FY24:
−103
FY25:
−56.3
Change from FY21 to FY25
millions USD
FY21:
−264
FY22:
81.7
FY23:
−34.6
FY24:
90.2
FY25:
53.5
Change from FY21 to FY25
millions USD
FY21:
165
FY22:
0.82
FY23:
136
FY24:
−0.12
FY25:
24.8
millions USD
FY21:
−182
FY22:
−1.22
FY23:
−5.31
FY24:
−12.8
FY25:
22.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−85.9
FY22:
−86.7
FY23:
−111
FY24:
−104
FY25:
−56.4
All amounts in millions USD